Health NGOs and advocacy organizations

Strategy& partners with non-governmental organizations worldwide to help advance a variety of health-related missions. We work with NGOs to define their strategic focus as well as help them build the capabilities needed to promote their mission, acting both on their own as well as in concert with other organizations. Strategy& brings particularly deep expertise in fostering collaborative partnerships across the NGO, private, and public sectors, working on topics related to access to medicines, corporate social responsibility, differential pricing and other key issues.


Our thought leadership

read more
GCC countries have made tremendous strides in providing healthcare to their citizens over the past decade.

read more health thought leadership >


Client examples

Global fund governance study
We worked directly with the Chair of the Global Fund to Fight AIDS, TB and Malaria to analyze and make recommendations to improve the Fund’s Board and Committee processes/structures.  As the Fund had evolved and matured, the charters and roles of some of the Board Committees had become less clear, and there were both overlaps and gaps in Committee responsibilities. Strategy& recommended a significant consolidation of Board Committees, and a re-definition of their roles and charters. The recommendations were accepted and implemented following the meeting at which they were presented and discussed.

GBCHealth
This coalition of over 230 companies working to improve the health of their workforces and communities around the world wanted to accelerate the adoption of good policies and practices among the suppliers of GBC members. Strategy& conducted a survey of GBC members, focusing on the Energy industry, of approaches to working with suppliers on improving health-related policies and practices. The most effective practices were documented as a practical ‘how-to’ guide for other GBC members, and the results were presented in the annual GBC awards meeting.

PEPFAR (Presidential Emergency Plan for AIDS Relief)
PEPFAR was concerned that purchases of antiretroviral medicines under the PEPFAR program would significantly overwhelm existing worldwide manufacturing capacity. Strategy& developed a detailed forecasting model of anticipated ARV requirements to achieve PEPFAR’s goal. We identified manufacturer capacity and quantified gaps between requirements and available capacity. Using the forecast and gap analyses, we worked with PEPFAR to develop strategies to ensure that manufacturers developed capacity to meet PEPFAR’s multi-year objectives.